15044-1-0107.qxp

For the most up-to-date Primary/Preferred Drug List visit www.caremark.com
The Caremark Primary/Preferred Drug List is a guide within select therapeutic categories for clients and their plan participants.
Generics should be considered the first line of prescribing. If there is no generic available, there may be more than one
brand name medicine to treat a condition. These preferred brand name medicines are listed to help identify products that are
clinically appropriate and cost-effective. Generics listed in therapeutic categories are for representational purposes only and not
meant to be all-inclusive. This list represents brand products in CAPS and generic products in lower case italics.
PLAN PARTICIPANT
HEALTHCARE PROVIDER
Your benefit plan provides you with a prescription benefit program Your patient is covered under a prescription benefit plan administered by administered by Caremark. Ask your doctor to consider prescribing, when Caremark. As a way to help manage healthcare costs, authorize generic medically appropriate, a preferred medicine from this list. Take this list substitution whenever possible. If you believe a brand name product is along when you or a covered family member sees a doctor.
necessary, consider prescribing a brand name on this list.
Please note:
Please note:
■ Your specific prescription benefit plan design may not cover certain ■ Generics should be considered the first line of prescribing.
categories, regardless of their appearance in this document.
■ This drug list is not inclusive nor does it guarantee coverage, but ■ For specific information regarding your prescription benefit coverage and represents a summary of prescription coverage.
co-pay1 information, please visit our Web site at www.caremark.com
■ The plan participant’s specific prescription benefit plan may have or contact a Caremark Customer Care representative.
a different co-pay1 for specific products on the list.
■ Caremark may contact your doctor after receiving your prescription to ■ Unless specifically indicated, drug list products will include all request consideration of a drug list product or generic equivalent. This may result in your doctor prescribing, when medically appropriate, a ■ Log in to www.caremark.com to check coverage and co-payments1
different brand name product or generic equivalent in place of your § MISCELLANEOUS
CHOLESTEROL ABSORPTION
§ ACE INHIBITOR/
CALCIUM CHANNEL
INHIBITORS
ANTIBACTERIALS
DIURETIC COMBINATIONS
BLOCKER/ANTILIPEMIC
COMBINATIONS
§ CEPHALOSPORINS
§ FIBRATES
§ ANTIFUNGALS
§ DIGITALIS GLYCOSIDES
§ HMG-CoA REDUCTASE
§ ERYTHROMYCINS/
INHIBITORS
MACROLIDES
§ DIURETICS
ANTIVIRALS
ACE INHIBITOR/CALCIUM
§ HERPES AGENTS
CHANNEL BLOCKERS
§ FLUOROQUINOLONES
§ INFLUENZA AGENTS
ANGIOTENSIN II
§ BETA-BLOCKERS
RECEPTOR ANTAGONISTS/
COMBINATIONS
§ PENICILLINS
§ ACE INHIBITORS
ANTILIPEMICS
ANTIDEPRESSANTS
§ MISCELLANEOUS AGENTS
ANTILIPEMIC COMBINATIONS
§ CALCIUM CHANNEL
BLOCKERS
§ BILE ACID RESINS
§ TETRACYCLINES
Your specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document.
§ SELECTIVE SEROTONIN
INSULIN SENSITIZERS
ESTROGENS
§ URINARY
LEUKOTRIENE RECEPTOR
REUPTAKE INHIBITORS
ANTISPASMODICS
ANTAGONISTS
INSULIN SENSITIZER/
BIGUANIDE COMBINATIONS
NASAL ANTIHISTAMINES
§ NASAL STEROIDS
INSULIN SENSITIZER/
SULFONYLUREA
§ TRANSDERMAL,
SEROTONIN
COMBINATIONS
ESTROGENS
NOREPINEPHRINE
§ ANTICOAGULANTS
REUPTAKE INHIBITORS
MEGLITINIDES
(SNRIs) 3
STEROID/BETA AGONISTS
§ SULFONYLUREAS
ORAL ESTROGEN/
ANAPHYLAXIS TREATMENT
STEROID INHALANTS
PROGESTINS
MIGRAINE
SELECTIVE SEROTONIN
AGONISTS
§ SULFONYLUREA/
BIGUANIDE COMBINATIONS
§ PROGESTINS
§ ANTICHOLINERGICS
DERMATOLOGY
ANTICHOLINERGIC/
SUPPLIES
MULTIPLE SCLEROSIS
SELECTIVE ESTROGEN
BETA AGONISTS
RECEPTOR MODULATORS
§ THYROID SUPPLEMENTS
ANTIHISTAMINES,
LOW SEDATING
BISPHOSPHONATES
ANDROGENS
§ ANTIHISTAMINES,
OPHTHALMIC
NONSEDATING
§ H2 RECEPTOR ANTAGONISTS fexofenadine
§ BETA-BLOCKERS,
ANTIDIABETICS
NONSELECTIVE
§ BIGUANIDES
§ ANTIHISTAMINE/
CONTRACEPTIVES
§ PROTON PUMP
DECONGESTANTS
§ MONOPHASIC
INHIBITORS
BETA-BLOCKERS, SELECTIVE
INSULINS
BETA AGONISTS
PROSTAGLANDINS
§ TRIPHASIC
§ SHORT ACTING
§ EXTENDED CYCLE
§ BENIGN PROSTATIC
HYPERPLASIA
§ SYMPATHOMIMETICS
TRANSDERMAL
LONG ACTING
QUICK REFERENCE PRIMARY/PREFERRED DRUG LIST
Your specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document.
FOR YOUR INFORMATION: Generics should be considered the first line of prescribing. This Caremark Drug List is not inclusive nor does it guarantee coverage, but represents a
summary of prescription coverage. Specific prescription benefit plan design may not cover certain categories, regardless of their appearance in this document. The plan participant's
prescription benefit plan may have a different co-pay1 for specific products on the list. Unless otherwise indicated, drug list products will include all dosage forms. This list represents
brand products in CAPS and generic products in lower case italics. Generics listed in therapeutic categories are for representational purposes only and are not meant to be all-inclusive.
Listed products may be available generically in certain strengths or dosage forms. Dosage forms on this list will be consistent with the category and use where listed. Log in to
www.caremark.com to check coverage and co-payments for a specific medicine.
§ Generics are available in this class and should be considered as the first line of prescribing.
1 Co-payment or co-pay means the amount a plan participant is required to pay for a prescription in accordance with a Plan, which may be a deductible, a percentage of the prescription price, a fixed amount or other charge, with the balance, if any, paid by a Plan.
2 Atacand should be reserved for patients who meet CHARM (Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity) trial criteria.
3 Indicates the proposed mechanism of action, based on the American Psychiatric Association Summary of Treatment Recommendations.
4 Higher co-payments may apply depending on the plan participant's specific prescription benefit plan. Log in to www.caremark.com to find the co-payment under a specific plan.
5 An Accu-Chek or OneTouch blood glucose meter will be provided at no charge by the manufacturer to those individuals currently using a meter other than Accu-Chek or OneTouch.
For more information on how to obtain a blood glucose meter, call toll-free: 1-800-588-4456.
Your privacy is important to us. Our employees are trained regarding the appropriate way to handle your private health information.
Caremark may receive rebates, discounts and service fees from pharmaceutical manufacturers for certain listed products.
This Caremark Drug List contains prescription brand name medicines that are registered or trademarks of pharmaceutical manufacturers that are not affiliated with Caremark Inc.
Listed products are for informational purposes only and are not intended to replace the clinical judgment of the prescriber.
2007 Caremark Inc. All rights reserved.
www.caremark.com

Source: http://www.healthplan.com/user-docs/000999_primary_CSDL.pdf

Consultants consortium members

Golden Gate Veterinary Pharmacy Educational Article Series 888-855-6337 Treating Urinary Incontinence in Dogs (Reprinted with permission from Vet Talk, a bi-monthly newsletter of the American College of Veterinary Pharmacists) Micturition (urination) disorders can create serious problems for pets and their owners. Untreated micturition disorders may lead to unresponsive urinary trac

someplacethatiselse.net

Buffy The Vampire Slayer Buff The Vampire Sla er The town is dark and quiet. Everyone has gone home for theThe to n is dark and uiet Ever one has gone home for thenight. We PUSH IN on the house. Again, dark and quiet. e PUSH IN on the house Again dark and uiet "My life closed twice before it's M life closed t ice before it sclose/ It yet remains to see. INT. BUFFY'S BEAR RIVER

Copyright © 2012-2014 Medical Theses